Personalized Dual-target RTMS for Patients with Refractory Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
SchizophreniaTranscranial Magnetic StimulationFunctional Magnetic Resonance Imaging (fMRI)
Interventions
DEVICE

Active rTMS was administered using a transcranial magnetic stimulator (Rapid2; MagStim).

Active rTMS was sequentially administered over the left DLPFC and left TPJ sites one hour apart, for 3 weeks (21 consecutive days), using a transcranial magnetic stimulator (Rapid2; MagStim) with a 70-mm air-cooled figure-of-eight coil. Stimulation at 20 Hz (2 seconds on, 28 seconds off) was applied over the left DLPFC with an intensity set at 100% of the individual resting motor threshold (RMT), delivering a total of 1,600 pulses daily. Continuous theta burst stimulation (cTBS) was applied over the left TPJ at either 100% of the individual RMT or at the highest intensity that the stimulator could deliver for this protocol (50% of maximum output). Three daily sessions of cTBS were administered, separated by two 15-minute breaks, delivering a total of 1,800 pulses daily. The coil was navigated in real-time using a frameless neuro-navigation system (Brainsight; Rogue Research, Montreal, Quebec, Canada).

Trial Locations (1)

230032

Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER